Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data.
Yasser AlbogamiYu-Jung J WeiAlmut G WintersteinPublished in: Pharmacoepidemiology and drug safety (2021)
Our findings suggest that the overall HRA population may represent the overall claims population and HRA provides certain data elements with satisfactory accuracy.